scholarly journals Clinical Pharmacist Intervention in a Primary Care Medical Group Reduces Financial Losses

2004 ◽  
Vol 10 (4) ◽  
pp. 355-355
Author(s):  
Frederic R. Curtiss
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Medical Group ◽  
Financial Losses ◽  
Clinical Pharmacist Intervention

scholarly journals Cost-consequence analysis evaluating multifaceted clinical pharmacist intervention targeting patient transitions of care from hospital to primary care

2018 ◽  
Vol 2 (2) ◽  
pp. 123-130 ◽  
Author(s):  
Maja Kjaer Rasmussen ◽  
Lene Vestergaard Ravn-Nielsen ◽  
Marie-Louise Duckert ◽  
Mia Lolk Lund ◽  
Jolene Pilegaard Henriksen ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Transitions Of Care ◽  
Consequence Analysis ◽  
Cost Consequence ◽  
Clinical Pharmacist Intervention

scholarly journals PCV122 THE IMPACT OF A CLINICAL PHARMACIST INTERVENTION ON LIPID-LOWERING IN A PRIMARY CARE SETTING

2010 ◽  
Vol 13 (7) ◽  
pp. A364
Author(s):  
N Triki ◽  
S Shani ◽  
D Rabinovich-Protter ◽  
D Mossinson ◽  
E Kokia ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Care Setting ◽  
Primary Care Setting ◽  
Pharmacist Intervention ◽  
Lipid Lowering ◽  
The Impact ◽  
Clinical Pharmacist Intervention

Description of a clinical pharmacist intervention administered to primary care patients with depression

2004 ◽  
Vol 26 (3) ◽  
pp. 210-218 ◽  
Author(s):  
Kathleen M Bungay ◽  
David A Adler ◽  
William H Rogers ◽  
Christopher McCoy ◽  
Maryann Kaszuba ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Primary Care Patients ◽  
Clinical Pharmacist Intervention

Pharmacist Review to Simplify Medication Regimens in a VAMC Primary Care Clinic

1996 ◽  
Vol 12 (2) ◽  
pp. 62-66 ◽  
Author(s):  
Paul V Laucka ◽  
Will B Webster ◽  
Jeffrey Kuch
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Primary Care Clinic ◽  
Intervention Group ◽  
Pharmacist Intervention ◽  
Control Group ◽  
Care Clinic ◽  
Before And After ◽  
Clinical Pharmacist Intervention ◽  
Clinic Visits

Objective: To assess the effect of a clinical pharmacist's prospective medication review of patients receiving multiple drug therapy, using the pharmaceutical care process, as determined by the number of concurrent medications the patient is receiving before and after clinic visits. Design: Assigned groups. Setting: Outpatient primary care clinic of a tertiary healthcare Veterans Affairs (VA) medical facility. Patients: Seven hundred twenty-seven patients who had eight or more active medication orders were selected. Four hundred forty-one patients (aged 67.2 ± 10.4 y) were in the intervention group; 286 others (aged 66.6 ± 11.9 y), whose medical records were not available, were assigned to the control group and received no clinical pharmacist intervention. Intervention: Medication regimens of VA ambulatory patients with eight or more active medications were reviewed by a clinical pharmacist, and a written communication to the prescriber was attached to the medical record. Main Outcome Measures: The number of active concurrent medications before and after clinic visits was measured. Results: There was a decrease in the medications in the intervention group from an average of 12.1 ±4 to 11.5 ± 4.2 (p < 0.05). The medications in the control group rose from an average of 11.8 ± 4.44 to 12.2 ± 4 (p = NS). A decrease of 0.6 prescriptions per patient was highly significant (p < 0.05). During the study, 1,336 recommendations were made to practitioners. From this group, 41% of the recommendations were accepted, and 477 medications were discontinued, the quantity dispensed or dosage was reduced, or an alternative medication was prescribed. Conclusions: These data suggest that clinical pharmacist intervention in an ambulatory care setting can affect practitioner prescribing habits and significantly decrease the number of medications prescribed.

scholarly journals Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia

2018 ◽  
Vol 18 (1) ◽  
pp. 81 ◽  
Author(s):  
Vina A. Sagita ◽  
Anton Bahtiar ◽  
Retnosari Andrajati
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
General Hospital ◽  
Clinical Pharmacist ◽  
Drug Effects ◽  
Pharmacist Intervention ◽  
Drug Related Problems ◽  
Clinical Problems ◽  
Clinical Pharmacist Intervention

Objectives: This study aimed to evaluate the role of a clinical pharmacist intervention in decreasing subsequent clinical and drug-related problems (DRPs) among coronary heart disease (CHD) inpatients with at least one previous DRP. Methods: This pre-experimental study with a pre-post design was carried out from January to April 2017 among inpatients with at least one previous DRP at a general hospital in Tangerang District, Banten, Indonesia. Clinical and DRPs were documented prospectively by a clinical pharmacist, with DRPs classified using Version 6.2 of the DRP classification scheme of the Pharmaceutical Care Network Europe Foundation. The intervention consisted of a discussion of identified DRPs with physicians, patients, pharmaceutical logistics clerks, nurses and nutritionists. Following this, any subsequent clinical and DRPs were re-identified and further interventions were conducted as necessary. Results: A total of 75 inpatients were included in the study. Pre-intervention, there were 443 DRPs and 202 clinical problems. The most frequent DRPs were adverse drug reactions (52.6%), followed by drug effects (41.8%). Most DRPs were of moderate severity and would have resulted in moderate consequences had the pharmacist not intervened. The interventions resulted in a significant reduction in the number of DRPs, type of DRPs and number of clinical problems (P <0.05 each). Patients with complications were 26.047 times more likely to have no reduction or an increased number of clinical problems compared to patients without complications (P <0.05). Conclusion: Clinical pharmacist interventions were found to reduce subsequent DRPs and clinical problems among CHD patients with at least one previous DRP.

Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam

2018 ◽  
Vol 33 (12) ◽  
pp. 711-722 ◽  
Author(s):  
Hilary J. Navy ◽  
Linda Weffald ◽  
Thomas Delate ◽  
Rachana J. Patel ◽  
Jennifer P. Dugan
Keyword(s):  
Older Adults ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Clinical Pharmacist Intervention
Sign in / Sign up

Export Citation Format

Share Document